Diggory P
Br J Vener Dis. 1983 Feb;59(1):8-10. doi: 10.1136/sti.59.1.8.
Of 9733 consecutive serological samples received by Portsmouth and Southampton Public Health Laboratories (PHL) and tested for syphilis, 190 (140 from men and 50 from women) gave positive results. Thirty new cases of syphilis were identified. Most sera were tested initially by both a specific antibody test (the Treponema pallidum haemaglutination (TPHA) test) and a cardiolipin test (the Venereal Disease Research Laboratory (VDRL) test). Among the 14 patients whose sera gave VDRL-positive but TPHA-negative results, 12 sera gave false-positive results. The sera of 90 patients gave TPHA-positive but VDRL-negative results; sera from only seven of these patients gave false-positive results. The VDRL test is very unlikely to identify a new case of syphilis where a TPHA test has failed to do so. The results of the survey suggest that the VDRL test should be withdrawn from initial testing for syphilis except where early primary disease is suspected.
朴茨茅斯和南安普敦公共卫生实验室(PHL)接收的9733份连续血清学样本进行梅毒检测,其中190份(140份来自男性,50份来自女性)结果呈阳性。确诊了30例梅毒新病例。大多数血清最初同时进行了特异性抗体检测(梅毒螺旋体血凝试验(TPHA))和心磷脂检测(性病研究实验室试验(VDRL))。在14例血清VDRL阳性但TPHA阴性的患者中,12份血清结果为假阳性。90例患者的血清TPHA阳性但VDRL阴性;其中只有7例患者的血清结果为假阳性。在TPHA检测未能确诊梅毒新病例的情况下,VDRL检测极不可能确诊。调查结果表明,除怀疑早期一期疾病外,VDRL检测应不再用于梅毒的初始检测。